<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Whole Body Vibration Review</title>
	<atom:link href="http://bodyvibratorsreview.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://bodyvibratorsreview.com</link>
	<description>Get information on whole body vibration systems.</description>
	<lastBuildDate>Fri, 11 May 2012 05:20:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>Need a little &#8216;fitspiration&#8217;? Try TODAY tips</title>
		<link>http://bodyvibratorsreview.com/644/need-a-little-fitspiration-try-today-tips/</link>
		<comments>http://bodyvibratorsreview.com/644/need-a-little-fitspiration-try-today-tips/#comments</comments>
		<pubDate>Fri, 11 May 2012 05:20:08 +0000</pubDate>
		<dc:creator>Greg</dc:creator>
				<category><![CDATA[General Health]]></category>

		<guid isPermaLink="false">http://bodyvibratorsreview.com/644/need-a-little-fitspiration-try-today-tips/</guid>
		<description><![CDATA[Have your healthiest summer yet! Ease into the dreaded &#8220;swimsuit season&#8221; with healthy tips from TODAY experts. All throughout May, we&#8217;ll offer smart do-it-yourself ways to look, eat and feel better. So stop stressing about that swimsuit, and read on.]]></description>
			<content:encoded><![CDATA[<p><a href="http://todayhealth.today.msnbc.msn.com/_news/2012/05/06/11540499-need-a-little-fitspiration-try-these-tips-from-today-readers?lite"><img align="left" border="0" src="http://bodyvibratorsreview.com/wp-content/plugins/wp-o-matic/cache/5179c_090406-smart-fitness-bcol12p.thumb.jpg" alt="Have your healthiest summer yet! Ease into the dreaded &quot;swimsuit season&quot; with healthy tips from TODAY experts. All throughout May, we'll offer smart do-it-yourself ways to look, eat and feel better. So stop stressing about that swimsuit, and read on." style="margin:0 5px 5px 0" /></a>Have your healthiest summer yet! Ease into the dreaded &#8220;swimsuit season&#8221; with healthy tips from TODAY experts. All throughout May, we&#8217;ll offer smart do-it-yourself ways to look, eat and feel better. So stop stressing about that swimsuit, and read on.</p>
<p>
<a href="http://ads.pheedo.com/click.phdo?s=84a07666c3a4603e701b802e4836e06d&amp;p=1"><img alt="" style="border: 0" border="0" src="http://ads.pheedo.com/img.phdo?s=84a07666c3a4603e701b802e4836e06d&amp;p=1" /></a><br />
<img alt="" height="0" width="0" border="0" src="http://tags.bluekai.com/site/5148" /><img alt="" height="0" width="0" border="0" src="http://bodyvibratorsreview.com/wp-content/plugins/wp-o-matic/cache/bfdd6_?ct=0:hmbmo83&amp;adv=wouzn4v&amp;fmt=3" /></p>
]]></content:encoded>
			<wfw:commentRss>http://bodyvibratorsreview.com/644/need-a-little-fitspiration-try-today-tips/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Japan&#8217;s Olympic swimmers defy altitude fears</title>
		<link>http://bodyvibratorsreview.com/643/japans-olympic-swimmers-defy-altitude-fears/</link>
		<comments>http://bodyvibratorsreview.com/643/japans-olympic-swimmers-defy-altitude-fears/#comments</comments>
		<pubDate>Fri, 11 May 2012 05:20:04 +0000</pubDate>
		<dc:creator>Greg</dc:creator>
				<category><![CDATA[General Health]]></category>
		<category><![CDATA[Alexander]]></category>
		<category><![CDATA[Altitude Training]]></category>
		<category><![CDATA[Fears]]></category>
		<category><![CDATA[London Games]]></category>
		<category><![CDATA[Norwegian]]></category>
		<category><![CDATA[Olympic Swimmers]]></category>
		<category><![CDATA[Reuters]]></category>
		<category><![CDATA[Tokyo Japan]]></category>

		<guid isPermaLink="false">http://bodyvibratorsreview.com/643/japans-olympic-swimmers-defy-altitude-fears/</guid>
		<description><![CDATA[TOKYO (Reuters) &#8211; Japan&#039;s Olympic swimmers will prepare for this year&#039;s London Games by undergoing altitude training as planned, despite the death of Norwegian Alexander Dale Oen last week.]]></description>
			<content:encoded><![CDATA[<p>TOKYO (Reuters) &#8211; Japan&#039;s Olympic swimmers will prepare for this year&#039;s London Games by undergoing altitude training as planned, despite the death of Norwegian Alexander Dale Oen last week.</p>
]]></content:encoded>
			<wfw:commentRss>http://bodyvibratorsreview.com/643/japans-olympic-swimmers-defy-altitude-fears/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Novartis to probe Indian drug approval allegations</title>
		<link>http://bodyvibratorsreview.com/642/novartis-to-probe-indian-drug-approval-allegations/</link>
		<comments>http://bodyvibratorsreview.com/642/novartis-to-probe-indian-drug-approval-allegations/#comments</comments>
		<pubDate>Fri, 11 May 2012 05:20:03 +0000</pubDate>
		<dc:creator>Greg</dc:creator>
				<category><![CDATA[General Health]]></category>
		<category><![CDATA[Allegations]]></category>
		<category><![CDATA[Colluded]]></category>
		<category><![CDATA[Drug Approval]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Irregularities]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[Parliamentary Report]]></category>
		<category><![CDATA[Pharmaceutical Firms]]></category>
		<category><![CDATA[Reuters]]></category>
		<category><![CDATA[Swiss]]></category>
		<category><![CDATA[Zurich]]></category>

		<guid isPermaLink="false">http://bodyvibratorsreview.com/642/novartis-to-probe-indian-drug-approval-allegations/</guid>
		<description><![CDATA[ZURICH (Reuters) &#8211; Swiss drugmaker Novartis said on Thursday it would investigate alleged drug approval irregularities in India after a parliamentary report found the country&#039;s regulator colluded with pharmaceutical firms to speed up approval &#8230;]]></description>
			<content:encoded><![CDATA[<p>ZURICH (Reuters) &#8211; Swiss drugmaker Novartis said on Thursday it would investigate alleged drug approval irregularities in India after a parliamentary report found the country&#039;s regulator colluded with pharmaceutical firms to speed up approval &#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://bodyvibratorsreview.com/642/novartis-to-probe-indian-drug-approval-allegations/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Warner Chilcott weighs sale, other options: report</title>
		<link>http://bodyvibratorsreview.com/641/warner-chilcott-weighs-sale-other-options-report/</link>
		<comments>http://bodyvibratorsreview.com/641/warner-chilcott-weighs-sale-other-options-report/#comments</comments>
		<pubDate>Tue, 01 May 2012 05:20:03 +0000</pubDate>
		<dc:creator>Greg</dc:creator>
				<category><![CDATA[General Health]]></category>
		<category><![CDATA[Goldman Sachs]]></category>
		<category><![CDATA[Nasdaq]]></category>
		<category><![CDATA[Options Report]]></category>
		<category><![CDATA[Private Equity]]></category>
		<category><![CDATA[Reuters]]></category>
		<category><![CDATA[Warner Chilcott]]></category>

		<guid isPermaLink="false">http://bodyvibratorsreview.com/641/warner-chilcott-weighs-sale-other-options-report/</guid>
		<description><![CDATA[(Reuters) &#8211; Warner Chilcott is evaluating options, including a possible sale of the company, after receiving interest from strategic and private-equity buyers, Bloomberg News reported on Monday. Goldman Sachs is helping the Nasdaq-listed drugmaker&#8230;]]></description>
			<content:encoded><![CDATA[<p>(Reuters) &#8211; Warner Chilcott is evaluating options, including a possible sale of the company, after receiving interest from strategic and private-equity buyers, Bloomberg News reported on Monday. Goldman Sachs is helping the Nasdaq-listed drugmaker&#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://bodyvibratorsreview.com/641/warner-chilcott-weighs-sale-other-options-report/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Actelion breathes easy on &quot;best case&quot; new drug data</title>
		<link>http://bodyvibratorsreview.com/640/actelion-breathes-easy-on-best-case-new-drug-data/</link>
		<comments>http://bodyvibratorsreview.com/640/actelion-breathes-easy-on-best-case-new-drug-data/#comments</comments>
		<pubDate>Tue, 01 May 2012 05:20:03 +0000</pubDate>
		<dc:creator>Greg</dc:creator>
				<category><![CDATA[General Health]]></category>
		<category><![CDATA[Biotech Company]]></category>
		<category><![CDATA[Clinical Trial]]></category>
		<category><![CDATA[Easy Case]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Heart Beat]]></category>
		<category><![CDATA[Heart Drug]]></category>
		<category><![CDATA[London Reuters]]></category>
		<category><![CDATA[New London]]></category>
		<category><![CDATA[Pipeline]]></category>
		<category><![CDATA[Zurich]]></category>

		<guid isPermaLink="false">http://bodyvibratorsreview.com/640/actelion-breathes-easy-on-best-case-new-drug-data/</guid>
		<description><![CDATA[ZURICH/LONDON (Reuters) &#8211; A new lung and heart drug from Actelion beat expectations in a key clinical trial, giving a much-needed boost to its pipeline and providing Europe&#039;s leading biotech company with a viable successor to its current top s&#8230;]]></description>
			<content:encoded><![CDATA[<p>ZURICH/LONDON (Reuters) &#8211; A new lung and heart drug from Actelion beat expectations in a key clinical trial, giving a much-needed boost to its pipeline and providing Europe&#039;s leading biotech company with a viable successor to its current top s&#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://bodyvibratorsreview.com/640/actelion-breathes-easy-on-best-case-new-drug-data/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Novo Nordisk rejects diabetes drug Victoza complaint</title>
		<link>http://bodyvibratorsreview.com/638/novo-nordisk-rejects-diabetes-drug-victoza-complaint/</link>
		<comments>http://bodyvibratorsreview.com/638/novo-nordisk-rejects-diabetes-drug-victoza-complaint/#comments</comments>
		<pubDate>Sat, 21 Apr 2012 05:20:04 +0000</pubDate>
		<dc:creator>Greg</dc:creator>
				<category><![CDATA[General Health]]></category>
		<category><![CDATA[Consumer Advocacy Group]]></category>
		<category><![CDATA[Copenhagen]]></category>
		<category><![CDATA[Danish]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[Diabetes Drug]]></category>
		<category><![CDATA[Novo Nordisk]]></category>
		<category><![CDATA[Regulators]]></category>
		<category><![CDATA[Reuters]]></category>

		<guid isPermaLink="false">http://bodyvibratorsreview.com/638/novo-nordisk-rejects-diabetes-drug-victoza-complaint/</guid>
		<description><![CDATA[COPENHAGEN (Reuters) &#8211; Danish drugmaker Novo Nordisk rejected a consumer advocacy group&#039;s complaint about its big-selling diabetes drug Victoza as groundless and said it did not expect U.S. regulators to take any action. Its shares initially d&#8230;]]></description>
			<content:encoded><![CDATA[<p>COPENHAGEN (Reuters) &#8211; Danish drugmaker Novo Nordisk rejected a consumer advocacy group&#039;s complaint about its big-selling diabetes drug Victoza as groundless and said it did not expect U.S. regulators to take any action. Its shares initially d&#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://bodyvibratorsreview.com/638/novo-nordisk-rejects-diabetes-drug-victoza-complaint/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Olympus: 71 percent approved of Sasa as new president</title>
		<link>http://bodyvibratorsreview.com/637/olympus-71-percent-approved-of-sasa-as-new-president/</link>
		<comments>http://bodyvibratorsreview.com/637/olympus-71-percent-approved-of-sasa-as-new-president/#comments</comments>
		<pubDate>Sat, 21 Apr 2012 05:20:03 +0000</pubDate>
		<dc:creator>Greg</dc:creator>
				<category><![CDATA[General Health]]></category>
		<category><![CDATA[Appointment]]></category>
		<category><![CDATA[Endo]]></category>
		<category><![CDATA[Incoming President]]></category>
		<category><![CDATA[New President]]></category>
		<category><![CDATA[Olympus]]></category>
		<category><![CDATA[Reuters]]></category>
		<category><![CDATA[Sasa]]></category>
		<category><![CDATA[Scandal]]></category>
		<category><![CDATA[Shareholders Meeting]]></category>
		<category><![CDATA[Tokyo Japan]]></category>

		<guid isPermaLink="false">http://bodyvibratorsreview.com/637/olympus-71-percent-approved-of-sasa-as-new-president/</guid>
		<description><![CDATA[TOKYO (Reuters) &#8211; Japan&#039;s Olympus Corp said on Friday that 70.74 percent of shareholders who cast votes at its extraordinary shareholders meeting had approved the appointment of incoming president Hiroyuki Sasa. The scandal-hit camera and endo&#8230;]]></description>
			<content:encoded><![CDATA[<p>TOKYO (Reuters) &#8211; Japan&#039;s Olympus Corp said on Friday that 70.74 percent of shareholders who cast votes at its extraordinary shareholders meeting had approved the appointment of incoming president Hiroyuki Sasa. The scandal-hit camera and endo&#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://bodyvibratorsreview.com/637/olympus-71-percent-approved-of-sasa-as-new-president/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>What are the 25 best cities for walking?</title>
		<link>http://bodyvibratorsreview.com/636/what-are-the-25-best-cities-for-walking/</link>
		<comments>http://bodyvibratorsreview.com/636/what-are-the-25-best-cities-for-walking/#comments</comments>
		<pubDate>Wed, 11 Apr 2012 05:20:05 +0000</pubDate>
		<dc:creator>Greg</dc:creator>
				<category><![CDATA[General Health]]></category>
		<category><![CDATA[Best Cities]]></category>
		<category><![CDATA[Everyday Life]]></category>
		<category><![CDATA[Exercise]]></category>
		<category><![CDATA[Motivation]]></category>

		<guid isPermaLink="false">http://bodyvibratorsreview.com/636/what-are-the-25-best-cities-for-walking/</guid>
		<description><![CDATA[Even though putting one foot in front of the other is the easiest form of exercise there is, it&#8217;s still hard to find the motivation to bypass the car and head out on foot in your everyday life. Here are 25 cities to get started.]]></description>
			<content:encoded><![CDATA[<p><a href="http://todayhealth.today.msnbc.msn.com/_news/2012/04/01/10944643-what-are-the-25-best-cities-for-walking"><img align="left" border="0" src="http://bodyvibratorsreview.com/wp-content/plugins/wp-o-matic/cache/dfb1e_pb-110607-high-line-04.thumb.jpg" alt="Even though putting one foot in front of the other is the easiest form of exercise there is, it's still hard to find the motivation to bypass the car and head out on foot in your everyday life. Here are 25 cities to get started." style="margin:0 5px 5px 0" /></a>Even though putting one foot in front of the other is the easiest form of exercise there is, it&#8217;s still hard to find the motivation to bypass the car and head out on foot in your everyday life. Here are 25 cities to get started.</p>
<p></p>
]]></content:encoded>
			<wfw:commentRss>http://bodyvibratorsreview.com/636/what-are-the-25-best-cities-for-walking/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Some AstraZeneca investors want CEO replaced -FT</title>
		<link>http://bodyvibratorsreview.com/635/some-astrazeneca-investors-want-ceo-replaced-ft/</link>
		<comments>http://bodyvibratorsreview.com/635/some-astrazeneca-investors-want-ceo-replaced-ft/#comments</comments>
		<pubDate>Wed, 11 Apr 2012 05:20:04 +0000</pubDate>
		<dc:creator>Greg</dc:creator>
				<category><![CDATA[General Health]]></category>
		<category><![CDATA[Astrazeneca]]></category>
		<category><![CDATA[Ceo]]></category>
		<category><![CDATA[David Brennan]]></category>
		<category><![CDATA[Executive Team]]></category>
		<category><![CDATA[Financial Times]]></category>
		<category><![CDATA[Investors]]></category>
		<category><![CDATA[London Reuters]]></category>
		<category><![CDATA[S Board]]></category>

		<guid isPermaLink="false">http://bodyvibratorsreview.com/635/some-astrazeneca-investors-want-ceo-replaced-ft/</guid>
		<description><![CDATA[LONDON (Reuters) &#8211; Some of AstraZeneca&#039;s biggest investors are calling for a radical shake-up of the drugmaker&#039;s board and executive team, including the replacement of David Brennan as CEO, the Financial Times reported on Monday. The move &#8230;]]></description>
			<content:encoded><![CDATA[<p>LONDON (Reuters) &#8211; Some of AstraZeneca&#039;s biggest investors are calling for a radical shake-up of the drugmaker&#039;s board and executive team, including the replacement of David Brennan as CEO, the Financial Times reported on Monday. The move &#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://bodyvibratorsreview.com/635/some-astrazeneca-investors-want-ceo-replaced-ft/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vaccines group gets cut-price rotavirus shots</title>
		<link>http://bodyvibratorsreview.com/634/vaccines-group-gets-cut-price-rotavirus-shots/</link>
		<comments>http://bodyvibratorsreview.com/634/vaccines-group-gets-cut-price-rotavirus-shots/#comments</comments>
		<pubDate>Wed, 11 Apr 2012 05:20:03 +0000</pubDate>
		<dc:creator>Greg</dc:creator>
				<category><![CDATA[General Health]]></category>
		<category><![CDATA[Gavi]]></category>
		<category><![CDATA[Glaxosmithkline]]></category>
		<category><![CDATA[London Reuters]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[Reuters International]]></category>
		<category><![CDATA[Rotavirus]]></category>
		<category><![CDATA[Two Thirds]]></category>
		<category><![CDATA[Vaccines Group]]></category>

		<guid isPermaLink="false">http://bodyvibratorsreview.com/634/vaccines-group-gets-cut-price-rotavirus-shots/</guid>
		<description><![CDATA[LONDON (Reuters) &#8211; International vaccines group GAVI has struck a deal for bulk buying rotavirus shots from GlaxoSmithKline and Merck which cuts the price by two-thirds and will allow poorer countries access to them at around $5 per course. The va&#8230;]]></description>
			<content:encoded><![CDATA[<p>LONDON (Reuters) &#8211; International vaccines group GAVI has struck a deal for bulk buying rotavirus shots from GlaxoSmithKline and Merck which cuts the price by two-thirds and will allow poorer countries access to them at around $5 per course. The va&#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://bodyvibratorsreview.com/634/vaccines-group-gets-cut-price-rotavirus-shots/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

